Drugs.com - FDA MedWatch Alerts

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

Audience: Consumers November 4, 2024 – Sacramento, CA, Boulla LLC is voluntarily recalling lot YZM240406, Exp 04/05/27, of ZoomMax Capsules and ZapMax Capsules packaged in 10-count blisters in a cardboard carton to the consumer level. The...

Feb 9, 2025 - 21:44
 0
Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac
Audience: Consumers November 4, 2024 – Sacramento, CA, Boulla LLC is voluntarily recalling lot YZM240406, Exp 04/05/27, of ZoomMax Capsules and ZapMax Capsules packaged in 10-count blisters in a cardboard carton to the consumer level. The...
Read More

Tags:

Previous Article

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Caps...

Next Article

FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs fro...

Related Posts

GURU INC. Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplement Capsules Due to Hidden Drug Ingredients

GURU INC. Issues Voluntary Nationwide Recall of Infla-6...

Feb 9, 2025  0

CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags Due to Visible Black Particulate Matter in a Single-Sealed Vial

CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9%...

Feb 26, 2025  0

C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga y Omega 3 Due to the Presence of Undeclared Drug Ingredients

C&A Naturistics Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0